Back HIV/AIDS

HIV / AIDS

AIDS 2012: Causes and Implications of Inflammation in People with HIV [VIDEO]

A growing body of evidence indicates that persistent inflammation and immune activation can cause a host of problems for people with HIV. Steven Deeks from the University of California San Francisco gave us a brief summary of HIV-related inflammation at the XIX International AIDS Conference (AIDS 2012) last week in Washington, DC.


alt

HIV Cure Research Highlights from AIDS 2012 [VIDEO]

A cure for HIV was among the key themes at the XIX International AIDS Conference (AIDS 2012) last week in Washington, DC. Sharon Lewin from Monash University in Melbourne -- co-chair of the 2014 International AIDS Conference -- gives us a recap of cure highlights presented at the meeting.alt

AIDS 2012: Once-daily Elvitegravir Suppresses HIV as well as Raltegravir at 96 weeks

The investigational HIV integrase inhibitor elvitegravir taken once-daily continued to perform as well as twice-daily raltegravir (Isentress) at 96 weeks for treatment-experienced people with extensive drug resistance, according to data presented last week at the 19th International AIDS Conference (AIDS 2012) in Washington, DC.

AIDS 2012: No HIV Found in Stem Cell Transplant Recipients Who Remain on ART

Two men who underwent bone marrow transplants for lymphoma using milder chemotherapy that allowed them to remain on antiretroviral therapy (ART) show no traces of HIV, researchers reportedlast week at the XIX International AIDS Conference (AIDS 2012) in Washington, DC. While not repeating the "Berlin Patient" HIV cure, these cases offer further insight into possible strategies for eradicating the virus.alt

AIDS 2012: Cobicistat Matches Ritonavir as Booster for Atazanavir

The novel boosting agent altcobicistat works as well as ritonavir (Norvir) as a pharmacoenhancer, or booster, for the first-line protease inhibitor atazanavir (Reyataz) at 48 weeks, according to a report presented last week at the 19th International AIDS Conference in Washington, DC.

AIDS 2012: Syringe Exchange Expansion in U.S. Would be Cost-saving

According to a mathematical analysis presented at the XIX International AIDS Conference (AIDS 2012) last week in Washington, DC, providing clean syringes to reduce HIV transmission among Americans who inject drugs is considerably less expensive than treating the new cases of HIV that would occur in the absence of this intervention.alt

AIDS 2012: Berlin Patient Timothy Brown Launches Foundation for HIV Cure [VIDEO]

Timothy Ray Brown -- better know as the "Berlin Patient," the first person known to be cured of HIV -- launched a new foundation to raise funds for HIV cure research at the XIX International AIDS Conference (AIDS 2012) last week in Washington, DC. He took the opportunity to announce that he is still free of HIV. alt